Lightspeed Venture Partners is a global venture capital firm established in 1998 that focuses on investing in early-stage companies across a diverse range of sectors. The firm targets technology-led businesses as well as non-technology opportunities in areas such as advertising and media, healthcare, education, financial services, and retail. It engages in various investment stages, including seed, early-stage, later-stage, and expansion-stage financing. Lightspeed specializes in debt financing for start-ups and growth companies while also exploring opportunities in consumer, enterprise, cleantech, and other markets. The firm is known for its strategic investments in innovative sectors, including big data, bitcoin, mobile technology, and software solutions.
Sarona 4 Zvi Strachilevich Street Tel Aviv 6473957 Israel
Vaibhav Agrawal
Associate Partner
Saquib AE
Partner
Mercedes Bent
Partner
Bhushan, Akshay
Partner
Chahal, Guru
Partner
Yoni Cheifetz
Partner
Chu M.D., Ph.D., Shelley
Partner
James Ephrati
Partner
Gaurav Gupta
Partner
David Gussarsky
Partner
Galym Imanbayev
Partner
Nnamdi Iregbulem
Partner
Raviraj Jain
Partner
Arif Janmohamed
Partner
Kareem, Ansaf
Partner
Khare, Dev
Partner
Harsha Kumar
Associate Partner
Pinn Lawjindakul
Partner
Pachara Lawjindakul
Partner
Will Leas
Partner
Liew, Jeremy
Partner
MacQuitty Ph.D., Jonathan J.
Venture Partner
Hemant Mohapatra
Partner
Andrew Moley
Operating Partner and CFO
Tal Morgenstern
Partner
Justin Overdorff
Partner
Nicole Quinn
General Partner
Chris Schaepe
Co-Founder
Shan Shan
Partner
Shuvi Shrivastava
Partner
Adam Smith
Partner
Bejul Somaia
Partner
Rahul Taneja
Partner
Twohig, Bradley
Partner
Anoushka Vaswani
Partner
Vitkauskas, Rytis
Partner
Ye, Jerry
Partner, Data Platform
Connor Love
Partner
Peter Nieh
Partner and Co-Founder
John Thompson
Venture Partner
James Alcorn
Partner
Alex Taussig
Partner
Past deals in Healthcare
Emversity
Seed Round in 2025
Emversity is an education organization focused on enhancing employability through vocational courses in the Allied Health Sciences. By developing an education technology platform, Emversity aims to bridge the gap between educational outcomes and industry requirements. The organization collaborates with industry experts to design programs that equip students with essential skills for success in the healthcare sector. Utilizing interactive learning methods, Emversity creates engaging and immersive educational experiences, empowering students with the knowledge and mindset necessary to thrive in a rapidly evolving job market.
Frontera Health
Seed Round in 2025
Frontera Health is changing autism care in underprivileged regions with AI-powered tools that assist physicians in evaluating and treating children with autism and related diseases.
Abridge
Series D in 2025
Abridge Inc. is a healthcare technology company founded in September 1999, focused on enhancing communication in medical settings through innovative tools. The company utilizes generative AI to automate the transcription and summarization of patient-clinician conversations, converting these interactions into structured clinical notes in real-time. This platform integrates seamlessly with Electronic Health Record (EHR) systems, significantly reducing the need for manual note-taking. By generating clear and understandable summaries, Abridge improves patient comprehension of medical discussions and ensures that relevant documentation is accurately recorded in patient files. Additionally, the company emphasizes data security and patient privacy, adhering to healthcare regulations while providing a customizable interface that caters to individual patient needs.
Eternal
Seed Round in 2025
With a mission to keep athletes active and thriving in their chosen sports for as long as possible, Eternal provides members with a holistic understanding of their health, fitness, and benchmarks for key markers of the aging process along with guidance from high-performance care teams to support every stage of an athlete’s journey.
Neko Health
Series B in 2025
Neko Health is a Swedish health-tech company focused on enhancing healthcare through prevention and early detection of diseases. It has developed innovative medical scanning technology that enables comprehensive and non-invasive health data collection, making it accessible and affordable for the general public. By leveraging sensor technology and artificial intelligence, Neko Health aims to reduce the prevalence of common diseases and their associated healthcare costs. The company provides doctors and clinicians with tools for flexible and cost-effective examinations, ultimately aiming to improve the quality of healthcare and promote proactive health management.
Anatomy Financial
Series A in 2024
Anatomy Financial offers a suite of financial automation solutions tailored for healthcare organizations that bill insurance. The services include AI-powered EOB conversion, smart reconciliation, and a modern healthcare lockbox to streamline financial workflows.
Soda Health
Series B in 2024
Soda Health is a healthcare technology company founded in 2021 and based in Chicago, Illinois. The company focuses on addressing health inequities by leveraging social determinants of health. It offers a technology platform designed to assist individuals in identifying, accessing, and funding the resources necessary for a healthy life. By providing a system for administering and reimbursing personalized benefits, Soda Health enables customers to effectively bridge the gap between medical claims and retail payments, ultimately promoting better health outcomes.
xAI
Series C in 2024
XAI develops artificial intelligence technologies for data analysis and decision-making. It uses machine learning algorithms to increase accuracy. XAI operates in finance, healthcare, and logistics industries.
Alpha9 Theranostics
Series C in 2024
Alpha9 Theranostics is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies. The company is creating a strong pipeline of radiopharmaceuticals to target solid and hematologic malignancies. Its systematic approach to radiotherapeutic design is fueled by a toolbox of technologies and chemistries, which offers broad potential for expansion into a multitude of oncology targets. Alpha9 Theranostics was founded in 2019 and is headquartered in Vancouver, Canada.
Tennr
Series B in 2024
Tennr is a healthcare AI startup focused on optimizing operational efficiency in the healthcare sector by automating back-office tasks. The company has developed a workflow automation platform that tracks the lifecycle of patient referrals, allowing healthcare staff to reduce the time spent on manual workflows, information verification, and data entry. By replacing traditional faxing systems and enhancing communication processes, Tennr's technology facilitates timely care for patients and helps healthcare practices of all sizes achieve enterprise-quality automation.
Air Doctor
Series B in 2024
Air Doctor Ltd. operates an online marketplace that connects travelers with verified medical practitioners, facilitating access to healthcare services while abroad. Founded in 2016 and based in Motza Illit, Israel, the platform enables users to search for and book appointments with a variety of healthcare providers, including doctors, dentists, emergency clinics, pharmacies, and laboratories. It features profiles of practitioners along with patient reviews, allowing travelers to select professionals who meet their specific needs and speak their language. By streamlining the process of obtaining medical care in unfamiliar locations, Air Doctor enhances the travel experience for individuals seeking healthcare services.
Scorpion Therapeutics
Series C in 2024
Scorpion Therapeutics, Inc. is a biotechnology company based in Boston, Massachusetts, focused on developing next-generation precision oncology technologies for cancer treatment. Founded in 2020, the company specializes in creating targeted small-molecule drugs that interact with validated cancer targets. Its research encompasses therapies aimed at known oncogenes, previously undruggable cancer targets, and novel targets. By integrating technologies across target discovery, medicinal chemistry, and translational medicine, Scorpion Therapeutics aims to advance a comprehensive pipeline of optimized compounds. The company's goal is to expand the reach of precision medicine, enabling healthcare professionals to offer innovative treatments to a broader range of cancer patients.
Triomics
Series A in 2024
Triomics is a generative AI-powered platform focused on enhancing the efficiency of clinical trials, particularly in the field of oncology. The company aims to accelerate trial enrollment and improve healthcare operations by addressing operational inefficiencies in data collection and patient recruitment. Leveraging its advanced AI technology, which is trained to understand health records and medical terminology, Triomics facilitates a more streamlined approach to clinical research. Its platform supports pharmaceutical companies and contract research organizations in conducting rapid and cost-effective trials, ultimately advancing oncology research and care.
Abridge
Series C in 2024
Abridge Inc. is a healthcare technology company founded in September 1999, focused on enhancing communication in medical settings through innovative tools. The company utilizes generative AI to automate the transcription and summarization of patient-clinician conversations, converting these interactions into structured clinical notes in real-time. This platform integrates seamlessly with Electronic Health Record (EHR) systems, significantly reducing the need for manual note-taking. By generating clear and understandable summaries, Abridge improves patient comprehension of medical discussions and ensures that relevant documentation is accurately recorded in patient files. Additionally, the company emphasizes data security and patient privacy, adhering to healthcare regulations while providing a customizable interface that caters to individual patient needs.
Anatomy Financial
Seed Round in 2024
Anatomy Financial offers a suite of financial automation solutions tailored for healthcare organizations that bill insurance. The services include AI-powered EOB conversion, smart reconciliation, and a modern healthcare lockbox to streamline financial workflows.
Emversity
Venture Round in 2023
Emversity is an education organization focused on enhancing employability through vocational courses in the Allied Health Sciences. By developing an education technology platform, Emversity aims to bridge the gap between educational outcomes and industry requirements. The organization collaborates with industry experts to design programs that equip students with essential skills for success in the healthcare sector. Utilizing interactive learning methods, Emversity creates engaging and immersive educational experiences, empowering students with the knowledge and mindset necessary to thrive in a rapidly evolving job market.
Ketryx
Series A in 2023
Ketryx, founded in 2021 and based in Cambridge, Massachusetts, specializes in software development tools aimed at the medical device sector. The company provides innovative solutions that integrate regulatory requirements and quality assurance processes, allowing teams to streamline their workflows. Ketryx's software connects all documentation, tests, and code into a single system that is traceable and navigable for FDA compliance. This approach enables regulated software teams to deliver safer and more reliable medical devices, ultimately fostering trust among patients globally.
Seismic Therapeutic
Series B in 2023
Seismic Therapeutic is a biotechnology company focused on accelerating immunology drug development through the integration of machine learning in the biologics discovery process. Its IMPACT™ platform addresses key challenges in biologics discovery by combining structural biology, protein engineering, and translational immunology. This innovative approach aims to create optimized therapies more efficiently, ultimately benefiting patients with autoimmune diseases and disorders linked to adaptive immune system dysregulation. With a robust pipeline of biologics, Seismic Therapeutic is committed to enhancing the speed and efficacy of drug development in the field of immunology.
Berry Health
Pre Seed Round in 2023
Berry Health is a consumer health startup dedicated to improving lives by addressing under-served and stigmatized medical conditions. The company specializes in remote diagnosis and treatment for chronic health issues through online private medical consultations. Berry Health provides prescription medications and nationwide delivery, empowering patients to take control of their health. The services offered cover a wide range of conditions, including dermatology, mental health, sexual health, hair loss, and more, benefiting both men and women. By focusing on enhancing patient agency, Berry Health aims to promote better health outcomes, reduce inflammation and pain, optimize immunity, and improve brain health.
Aledade
Series F in 2023
Aledade, Inc. is a health technology company that supports primary care physicians in establishing and managing accountable care organizations (ACOs) across the United States. Founded in 2014 and based in Bethesda, Maryland, Aledade partners with independent primary care providers to offer a comprehensive suite of services, including data analytics, guided workflows, regulatory expertise, and payer relationships. The company also provides 360° practice support, workflow optimization, and assistance with ACO governance and contracting. By leveraging its technology platform, Aledade enables physicians to access integrated data and insights that help improve patient care, reduce costs, and maintain the autonomy of independent practices. Its tailored solutions cater to a diverse range of healthcare providers, including small practices, large practices, community health centers, and multispecialty groups.
HealthPlix
Series C in 2023
HealthPlix is a pioneering digital health company in India that offers an AI-powered electronic medical record (EMR) platform designed to enhance healthcare delivery. The platform supports over 10,000 doctors across more than 370 cities, facilitating the treatment of over 22 million patients in various specialties. HealthPlix's technology provides clinical decision support at the point of care, particularly focusing on chronic diseases such as diabetes. The EMR system allows for personalized consultations based on individual patient histories and supports prescription generation in multiple languages, thus helping doctors transition from traditional paper-based methods to a more efficient digital approach.
Fathom
Series B in 2022
Fathom Health, founded in 2016 and based in San Francisco, California, provides artificial intelligence solutions aimed at streamlining the medical reimbursement process. The company has developed a coding automation platform that expedites medical coding practices by automatically reviewing incoming charts. In addition to this technology, Fathom offers full-service coding solutions and real-time comprehensive audits, allowing healthcare providers to enhance operational efficiency through automation. By leveraging AI, Fathom enables medical operators to optimize their coding processes, ultimately improving their business outcomes.
Soda Health
Series A in 2022
Soda Health is a healthcare technology company founded in 2021 and based in Chicago, Illinois. The company focuses on addressing health inequities by leveraging social determinants of health. It offers a technology platform designed to assist individuals in identifying, accessing, and funding the resources necessary for a healthy life. By providing a system for administering and reimbursing personalized benefits, Soda Health enables customers to effectively bridge the gap between medical claims and retail payments, ultimately promoting better health outcomes.
Theranica
Series C in 2022
Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, and affordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.
WonderMind
Seed Round in 2022
WonderMind is a mental fitness ecosystem dedicated to democratizing and destigmatizing mental health on a global scale. Founded by Selena Gomez, Mandy Teefey, and Daniella Pierson, the company focuses on providing accessible and affordable mental wellness solutions. Through its platform, WonderMind offers customized peer-to-peer support, engaging daily content, and consumer packaged goods designed to prioritize mental fitness. The company's mission is to empower individuals by enhancing their understanding of mental health, encouraging personal growth, and improving overall well-being.
Ancora Biotech
Series A in 2022
Developer of antibody biotherapeutics drugs intended to develop a treatment for several life-threatening diseases. The company focuses on clinical development support for the treatment of B cell cancers, inflammatory and metabolic disorders, and chronic hepatitis B infections, enabling healthcare workers to treat patients with various life-threatening diseases.
Ultima Genomics
Venture Round in 2022
Ultima Genomics is unleashing the power of genomics at scale. Ultima Genomics drives the scale of genomic information to enable unprecedented advances in biology and improvements in human health. The company was founded in 2016 and is based in Newark, California.
Air Doctor
Series B in 2022
Air Doctor Ltd. operates an online marketplace that connects travelers with verified medical practitioners, facilitating access to healthcare services while abroad. Founded in 2016 and based in Motza Illit, Israel, the platform enables users to search for and book appointments with a variety of healthcare providers, including doctors, dentists, emergency clinics, pharmacies, and laboratories. It features profiles of practitioners along with patient reviews, allowing travelers to select professionals who meet their specific needs and speak their language. By streamlining the process of obtaining medical care in unfamiliar locations, Air Doctor enhances the travel experience for individuals seeking healthcare services.
NyquistAI
Seed Round in 2022
NyquistAI is focused on providing a comprehensive platform for accessing and analyzing life science data. Utilizing advanced machine learning technology, NyquistAI combines unstructured data from global clinical trials and real-world sources to deliver valuable insights for healthcare professionals. The platform aims to enhance research capabilities and inform business strategies by offering up-to-date and credible information that spans the entire innovation lifecycle in the medical technology sector. With customizable solutions, NyquistAI enables users to efficiently compile and interpret crucial data, thereby supporting informed decision-making and fostering innovative opportunities in the life sciences field.
MDClone
Series C in 2022
MDClone Ltd. is a company that specializes in developing software for analyzing medical records while ensuring the privacy of patient data. Founded in 2016 and based in Beersheba, Israel, MDClone's platform generates synthetic medical records for fictitious patients, which allows researchers to study disease behavior, healthcare practices, and treatment outcomes without exposing actual patient information. The MDClone ADAMS Platform provides a self-service data analytics environment that facilitates exploration, discovery, and collaboration across healthcare systems, both nationally and internationally. This innovative approach addresses common barriers in healthcare by enabling users to organize and access data efficiently, thereby improving operations and enhancing patient outcomes. MDClone serves various clients in the healthcare sector, including major health systems, payers, and life sciences organizations in the United States, Canada, and Israel.
Seismic Therapeutic
Series A in 2022
Seismic Therapeutic is a biotechnology company focused on accelerating immunology drug development through the integration of machine learning in the biologics discovery process. Its IMPACT™ platform addresses key challenges in biologics discovery by combining structural biology, protein engineering, and translational immunology. This innovative approach aims to create optimized therapies more efficiently, ultimately benefiting patients with autoimmune diseases and disorders linked to adaptive immune system dysregulation. With a robust pipeline of biologics, Seismic Therapeutic is committed to enhancing the speed and efficacy of drug development in the field of immunology.
Curve Health
Series A in 2022
Curve Health, Inc. is an innovative online platform focused on enhancing senior care by integrating telemedicine, health information exchange, predictive analytics, and smart billing. Founded in 2020 and based in New York, the platform facilitates remote care for patients in skilled nursing facilities, at home, and in emergency situations, significantly reducing the need for patient transfers to emergency departments. By streamlining communication and operations between healthcare providers and post-acute facilities, Curve Health improves care quality and patient outcomes while optimizing resource allocation. The platform also accelerates reimbursement processes and automates documentation, making it a comprehensive solution for modern healthcare challenges in senior care.
HilleVax
Venture Round in 2021
HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines. HilleVax was founded in 2021 and was headquartered in Boston, Massachusetts.
NeuralGalaxy
Series A in 2021
Neural Galaxy is a brain science company that emerged from Harvard Medical School and the Massachusetts Institute of Technology. The organization focuses on addressing brain disorders through advanced software and hardware technologies. By leveraging breakthrough research in brain science, Neural Galaxy aims to enhance understanding of the brain and high-level intelligence. Its mission includes tackling significant challenges related to brain diseases and improving treatment options, ultimately contributing to a deeper comprehension of human cognition and enhancing overall societal intelligence.
Soda Health
Seed Round in 2021
Soda Health is a healthcare technology company founded in 2021 and based in Chicago, Illinois. The company focuses on addressing health inequities by leveraging social determinants of health. It offers a technology platform designed to assist individuals in identifying, accessing, and funding the resources necessary for a healthy life. By providing a system for administering and reimbursing personalized benefits, Soda Health enables customers to effectively bridge the gap between medical claims and retail payments, ultimately promoting better health outcomes.
3T Biosciences
Series A in 2021
Founded in 2017, 3T Biosciences is an immunotherapy company headquartered in Menlo Park, California.
HealthPlix
Series B in 2021
HealthPlix is a pioneering digital health company in India that offers an AI-powered electronic medical record (EMR) platform designed to enhance healthcare delivery. The platform supports over 10,000 doctors across more than 370 cities, facilitating the treatment of over 22 million patients in various specialties. HealthPlix's technology provides clinical decision support at the point of care, particularly focusing on chronic diseases such as diabetes. The EMR system allows for personalized consultations based on individual patient histories and supports prescription generation in multiple languages, thus helping doctors transition from traditional paper-based methods to a more efficient digital approach.
Curve Health
Seed Round in 2020
Curve Health, Inc. is an innovative online platform focused on enhancing senior care by integrating telemedicine, health information exchange, predictive analytics, and smart billing. Founded in 2020 and based in New York, the platform facilitates remote care for patients in skilled nursing facilities, at home, and in emergency situations, significantly reducing the need for patient transfers to emergency departments. By streamlining communication and operations between healthcare providers and post-acute facilities, Curve Health improves care quality and patient outcomes while optimizing resource allocation. The platform also accelerates reimbursement processes and automates documentation, making it a comprehensive solution for modern healthcare challenges in senior care.
Lark
Series C in 2020
Lark is a developer of a virtual chronic disease prevention and management platform that offers personalized support and counseling to users. Utilizing advanced artificial intelligence alongside human coaches and connected devices, Lark provides real-time, 24/7 assistance, helping individuals make healthier choices and manage chronic conditions effectively. The company has established CDC-recognized programs, including its Diabetes Prevention Program, Wellness Program, Diabetes Care Program, and Hypertension Program, which collectively serve 1.5 million users. These initiatives have shown clinically validated improvements in health outcomes, as documented in 11 peer-reviewed journals and analyst reports. Founded in 2011 by Julia Hu and Jeff Zira, Lark is headquartered in Mountain View, California.
Orca Bio
Series D in 2020
Orca Bio is a clinical-stage cell therapy company focused on providing curative treatments for patients suffering from malignant and autoimmune diseases. The company has developed proprietary technologies aimed at replacing diseased blood and immune systems with healthy cells. Orca Bio specializes in the research and development of innovative cell therapies that enhance the effectiveness of bone marrow transplants, creating a life-saving platform for various medical conditions. With a team of leading experts and technologists, Orca Bio is committed to advancing its pipeline of therapies to improve patient outcomes and transform healthcare practices.
MDClone
Series B in 2019
MDClone Ltd. is a company that specializes in developing software for analyzing medical records while ensuring the privacy of patient data. Founded in 2016 and based in Beersheba, Israel, MDClone's platform generates synthetic medical records for fictitious patients, which allows researchers to study disease behavior, healthcare practices, and treatment outcomes without exposing actual patient information. The MDClone ADAMS Platform provides a self-service data analytics environment that facilitates exploration, discovery, and collaboration across healthcare systems, both nationally and internationally. This innovative approach addresses common barriers in healthcare by enabling users to organize and access data efficiently, thereby improving operations and enhancing patient outcomes. MDClone serves various clients in the healthcare sector, including major health systems, payers, and life sciences organizations in the United States, Canada, and Israel.
Theranica
Series B in 2019
Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, and affordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.
TeneoBio
Venture Round in 2018
TeneoBio, Inc. is a biotechnology company focused on developing human heavy chain antibodies, known as UniAbs, for therapeutic applications in cancer, autoimmunity, and infectious diseases. Since its founding in 2009 and headquartered in Menlo Park, California, the company has advanced several products targeting conditions such as multiple myeloma, prostate cancer, immune disorders, and AIDS. TeneoBio utilizes its proprietary antibody discovery platform, which includes genetically engineered animals and advanced technologies like next-generation sequencing and bioinformatics. This platform enables the rapid identification of unique binding molecules, facilitating the development of bispecific and trispecific antibodies as well as immune checkpoint inhibitors. The company aims to enhance patients' immune responses to overcome various diseases and disorders.
Innovaccer
Series B in 2018
Innovaccer Inc. develops analytical and data science applications primarily for the healthcare sector, while also serving financial services, manufacturing, retail, and academic research organizations. The company offers a comprehensive Healthcare Intelligence Cloud, which aggregates and analyzes patient data from various sources, including electronic health records and medical devices. This platform enhances patient care and operational efficiency by providing tools for risk adjustment, population health management, and care coordination. Key solutions include Datashop, which features modules for patient insights, economic market analysis, and healthcare trend datasets, as well as a Clinical Documentation Improvement solution to enhance documentation integrity. Innovaccer's offerings also include care navigation, billing, and claims processing tools to streamline operations and improve patient outcomes. The company has established partnerships to further its impact and operates globally from its headquarters in Noida, India, with an office in Palo Alto, California. Founded in 2012, Innovaccer remains committed to transforming healthcare delivery through its innovative technology platform.
MDClone
Series A in 2018
MDClone Ltd. is a company that specializes in developing software for analyzing medical records while ensuring the privacy of patient data. Founded in 2016 and based in Beersheba, Israel, MDClone's platform generates synthetic medical records for fictitious patients, which allows researchers to study disease behavior, healthcare practices, and treatment outcomes without exposing actual patient information. The MDClone ADAMS Platform provides a self-service data analytics environment that facilitates exploration, discovery, and collaboration across healthcare systems, both nationally and internationally. This innovative approach addresses common barriers in healthcare by enabling users to organize and access data efficiently, thereby improving operations and enhancing patient outcomes. MDClone serves various clients in the healthcare sector, including major health systems, payers, and life sciences organizations in the United States, Canada, and Israel.
Arctic Wolf
Series B in 2018
Arctic Wolf Networks, Inc. is a cybersecurity company that provides security operations center-as-a-service to businesses, enabling them to manage and mitigate cyber risks effectively. The company offers a range of services, including cloud infrastructure monitoring, software-as-a-service application monitoring, vulnerability assessments, and account takeover risk detection. It also develops the Arctic Wolf Agent, a software tool that collects actionable intelligence from IT environments. Serving industries such as financial services, healthcare, and legal, Arctic Wolf employs a concierge security model, where its engineers work closely with clients to deliver tailored threat detection, response, and ongoing risk management. Founded in 2012 and headquartered in Eden Prairie, Minnesota, the company also has offices in Provo, Utah, and Waterloo, Canada.
Forty Seven
Series B in 2017
Forty Seven, Inc. is a clinical-stage immuno-oncology company based in Menlo Park, California, focused on developing innovative therapies to activate macrophages in the fight against cancer. The company's lead candidate, a monoclonal antibody targeting the CD47 receptor, aims to counteract the "don't eat me" signal that cancer cells use to evade the immune system. This antibody is currently undergoing evaluation in multiple clinical trials for various cancers, including solid tumors, acute myeloid leukemia, non-Hodgkin's lymphoma, and colorectal carcinoma. In addition to its flagship program, Forty Seven is advancing other antibodies, such as FSI-189, which binds to SIRPa, and FSI-174, an anti-cKIT antibody. The company has established collaborations with Genentech and Acerta Pharma to explore additional treatment combinations in non-Hodgkin's lymphoma and diffuse large B-cell lymphoma. Founded in 2014, Forty Seven operates as a subsidiary of Gilead Sciences.
Cairns Health
Seed Round in 2017
Cairns Health is a digital care companion and enablement platform for senior living and home care. The company's digital care plan enablement solution integrates intelligent ambient sensing (radar), artificial intelligence (AI) and large language models (LLM's) to streamline caregiver-patient interactions, boost engagement, and empower patients with a better understanding of their care plans, leading to timely interventions that improve care while reducing overall care delivery costs.
Theranica
Series A in 2017
Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, and affordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.
Collectly
Pre Seed Round in 2017
Collectly, Inc. is a company that specializes in debt recovery software, primarily aimed at healthcare organizations. Founded in 2016 and based in Walnut, California, Collectly offers a platform that automates the collection of overdue payments from business customers. The software tracks outstanding invoices, analyzes potential overdue payments, and communicates with customers through automated emails and chat. It enhances the patient financial experience by streamlining revenue cycle operations, facilitating online payments, and enabling customizable payment plans. By leveraging data-driven insights and artificial intelligence, Collectly assists medical practices and hospitals in improving patient collections and reducing accounts receivable, ultimately simplifying the billing process for both providers and patients.
PlushCare
Series A in 2016
PlushCare is a San Francisco-based tech startup that makes it easy to find and meet with a doctor online, even on the same day. Their mission is to provide patients with the best doctors and the best medical experience in a friendly and personalized way. The company's technology platform enables over 100,000 patients (and growing) to get care from a board-certified doctor online. With an NPS of 90 and an App Store rating of 4.9, they strive to provide the healthcare experience that patients deserve. PlushCare has also been developing Coronavirus at home testing.
Innovaccer
Series A in 2016
Innovaccer Inc. develops analytical and data science applications primarily for the healthcare sector, while also serving financial services, manufacturing, retail, and academic research organizations. The company offers a comprehensive Healthcare Intelligence Cloud, which aggregates and analyzes patient data from various sources, including electronic health records and medical devices. This platform enhances patient care and operational efficiency by providing tools for risk adjustment, population health management, and care coordination. Key solutions include Datashop, which features modules for patient insights, economic market analysis, and healthcare trend datasets, as well as a Clinical Documentation Improvement solution to enhance documentation integrity. Innovaccer's offerings also include care navigation, billing, and claims processing tools to streamline operations and improve patient outcomes. The company has established partnerships to further its impact and operates globally from its headquarters in Noida, India, with an office in Palo Alto, California. Founded in 2012, Innovaccer remains committed to transforming healthcare delivery through its innovative technology platform.
Zhangshang Yaodian
Series B in 2016
Zhangshang Yaodian is a pharmacy app that provides safe medication services.
Forty Seven
Series A in 2016
Forty Seven, Inc. is a clinical-stage immuno-oncology company based in Menlo Park, California, focused on developing innovative therapies to activate macrophages in the fight against cancer. The company's lead candidate, a monoclonal antibody targeting the CD47 receptor, aims to counteract the "don't eat me" signal that cancer cells use to evade the immune system. This antibody is currently undergoing evaluation in multiple clinical trials for various cancers, including solid tumors, acute myeloid leukemia, non-Hodgkin's lymphoma, and colorectal carcinoma. In addition to its flagship program, Forty Seven is advancing other antibodies, such as FSI-189, which binds to SIRPa, and FSI-174, an anti-cKIT antibody. The company has established collaborations with Genentech and Acerta Pharma to explore additional treatment combinations in non-Hodgkin's lymphoma and diffuse large B-cell lymphoma. Founded in 2014, Forty Seven operates as a subsidiary of Gilead Sciences.
Tencent Trusted Doctors
Series B in 2015
Tencent Trusted Doctors, a company established in early August 2018 upon the merger of Tencent Doctorwork and Trusted Doctors, is acquiring the start-up in an attempt to create a private healthcare network that provides both online and offline services through the so-called "celebrity effect".
Tencent Trusted Doctors
Series A in 2014
Tencent Trusted Doctors, a company established in early August 2018 upon the merger of Tencent Doctorwork and Trusted Doctors, is acquiring the start-up in an attempt to create a private healthcare network that provides both online and offline services through the so-called "celebrity effect".
Acupera Inc.
Series A in 2014
Acupera provides digital health solutions that enable healthcare provider organizations to deliver efficient, effective care to their patient population. Through its scalable, cloud-based population health and care coordination technology, Acupera empowers healthcare providers to better manage care while achieving their operating and performance goals.
Cognito
Seed Round in 2014
Cognito specializes in intelligent identity verification solutions, offering a platform that enables businesses to verify customer identities for compliance and anti-fraud purposes. Its identity verification APIs assess various data points, including name, date of birth, address, and identification numbers, ensuring compliance with Know Your Customer (KYC) regulations. The company serves diverse sectors such as crowdfunding, virtual currency, healthcare, and on-demand services. Founded in 2013 and based in Palo Alto, California, Cognito was previously known as BlockScore, Inc. before rebranding in 2014. The platform is designed to streamline the verification process, addressing common challenges faced by developers in integrating identity verification within their applications.
EPINOMICS
Funding Round in 2014
Epinomics is revolutionizing personalized medicine through scientific research, deep analytics, and clinical application development.
Cognito
Seed Round in 2013
Cognito specializes in intelligent identity verification solutions, offering a platform that enables businesses to verify customer identities for compliance and anti-fraud purposes. Its identity verification APIs assess various data points, including name, date of birth, address, and identification numbers, ensuring compliance with Know Your Customer (KYC) regulations. The company serves diverse sectors such as crowdfunding, virtual currency, healthcare, and on-demand services. Founded in 2013 and based in Palo Alto, California, Cognito was previously known as BlockScore, Inc. before rebranding in 2014. The platform is designed to streamline the verification process, addressing common challenges faced by developers in integrating identity verification within their applications.
Arctic Wolf
Venture Round in 2012
Arctic Wolf Networks, Inc. is a cybersecurity company that provides security operations center-as-a-service to businesses, enabling them to manage and mitigate cyber risks effectively. The company offers a range of services, including cloud infrastructure monitoring, software-as-a-service application monitoring, vulnerability assessments, and account takeover risk detection. It also develops the Arctic Wolf Agent, a software tool that collects actionable intelligence from IT environments. Serving industries such as financial services, healthcare, and legal, Arctic Wolf employs a concierge security model, where its engineers work closely with clients to deliver tailored threat detection, response, and ongoing risk management. Founded in 2012 and headquartered in Eden Prairie, Minnesota, the company also has offices in Provo, Utah, and Waterloo, Canada.
Nimble Storage
Series E in 2012
Nimble Storage, Inc. specializes in flash storage solutions, providing a range of products that include all-flash arrays, adaptive flash arrays, and multi-cloud storage services. The company's offerings are designed to enhance performance and simplify operations for various business applications, including databases, virtual servers, and data analytics. Nimble's patented Cache Accelerated Sequential Layout (CASL) architecture combines flash with high-capacity drives, enabling high performance at an affordable cost while improving disaster recovery and backup processes. Their predictive cloud platform, InfoSight, incorporates predictive analytics to optimize storage management across on-premises data centers and cloud environments. Nimble Cloud Volumes allow customers to run applications in leading cloud services like Amazon Web Services and Microsoft Azure. The company distributes its products through a network of value-added resellers and integrators, serving diverse sectors including healthcare, finance, education, and technology. Founded in 2007 and based in San Jose, California, Nimble Storage operates as a subsidiary of Hewlett Packard Enterprise Company.
Arctic Wolf
Series A in 2012
Arctic Wolf Networks, Inc. is a cybersecurity company that provides security operations center-as-a-service to businesses, enabling them to manage and mitigate cyber risks effectively. The company offers a range of services, including cloud infrastructure monitoring, software-as-a-service application monitoring, vulnerability assessments, and account takeover risk detection. It also develops the Arctic Wolf Agent, a software tool that collects actionable intelligence from IT environments. Serving industries such as financial services, healthcare, and legal, Arctic Wolf employs a concierge security model, where its engineers work closely with clients to deliver tailored threat detection, response, and ongoing risk management. Founded in 2012 and headquartered in Eden Prairie, Minnesota, the company also has offices in Provo, Utah, and Waterloo, Canada.
Nimble Storage
Series D in 2011
Nimble Storage, Inc. specializes in flash storage solutions, providing a range of products that include all-flash arrays, adaptive flash arrays, and multi-cloud storage services. The company's offerings are designed to enhance performance and simplify operations for various business applications, including databases, virtual servers, and data analytics. Nimble's patented Cache Accelerated Sequential Layout (CASL) architecture combines flash with high-capacity drives, enabling high performance at an affordable cost while improving disaster recovery and backup processes. Their predictive cloud platform, InfoSight, incorporates predictive analytics to optimize storage management across on-premises data centers and cloud environments. Nimble Cloud Volumes allow customers to run applications in leading cloud services like Amazon Web Services and Microsoft Azure. The company distributes its products through a network of value-added resellers and integrators, serving diverse sectors including healthcare, finance, education, and technology. Founded in 2007 and based in San Jose, California, Nimble Storage operates as a subsidiary of Hewlett Packard Enterprise Company.
Lark
Seed Round in 2011
Lark is a developer of a virtual chronic disease prevention and management platform that offers personalized support and counseling to users. Utilizing advanced artificial intelligence alongside human coaches and connected devices, Lark provides real-time, 24/7 assistance, helping individuals make healthier choices and manage chronic conditions effectively. The company has established CDC-recognized programs, including its Diabetes Prevention Program, Wellness Program, Diabetes Care Program, and Hypertension Program, which collectively serve 1.5 million users. These initiatives have shown clinically validated improvements in health outcomes, as documented in 11 peer-reviewed journals and analyst reports. Founded in 2011 by Julia Hu and Jeff Zira, Lark is headquartered in Mountain View, California.
Nimble Storage
Series C in 2010
Nimble Storage, Inc. specializes in flash storage solutions, providing a range of products that include all-flash arrays, adaptive flash arrays, and multi-cloud storage services. The company's offerings are designed to enhance performance and simplify operations for various business applications, including databases, virtual servers, and data analytics. Nimble's patented Cache Accelerated Sequential Layout (CASL) architecture combines flash with high-capacity drives, enabling high performance at an affordable cost while improving disaster recovery and backup processes. Their predictive cloud platform, InfoSight, incorporates predictive analytics to optimize storage management across on-premises data centers and cloud environments. Nimble Cloud Volumes allow customers to run applications in leading cloud services like Amazon Web Services and Microsoft Azure. The company distributes its products through a network of value-added resellers and integrators, serving diverse sectors including healthcare, finance, education, and technology. Founded in 2007 and based in San Jose, California, Nimble Storage operates as a subsidiary of Hewlett Packard Enterprise Company.
Kosmix
Series D in 2008
Kosmix is a web navigation platform that allows users to explore the Internet by topic, presenting an organized dashboard of relevant videos, photos, news, commentary, and links. Founded in 2005 by Venky Harinarayan and Anand Rajaraman in Mountain View, California, Kosmix employs a content categorization engine to filter and organize information, helping users navigate the web effectively even when they are unsure of their specific interests. The company's initial foray into vertical search was marked by the launch of RightHealth.com, which has since become a leading health site. In 2008, Kosmix expanded its focus to provide a broader range of topic-based exploration. The company has received funding from notable investors, including Accel Partners, Lightspeed Venture Partners, and Bezos Expeditions, and aims to streamline the way users discover and interact with online content amidst the overwhelming volume of information available.
Kosmix
Series C in 2007
Kosmix is a web navigation platform that allows users to explore the Internet by topic, presenting an organized dashboard of relevant videos, photos, news, commentary, and links. Founded in 2005 by Venky Harinarayan and Anand Rajaraman in Mountain View, California, Kosmix employs a content categorization engine to filter and organize information, helping users navigate the web effectively even when they are unsure of their specific interests. The company's initial foray into vertical search was marked by the launch of RightHealth.com, which has since become a leading health site. In 2008, Kosmix expanded its focus to provide a broader range of topic-based exploration. The company has received funding from notable investors, including Accel Partners, Lightspeed Venture Partners, and Bezos Expeditions, and aims to streamline the way users discover and interact with online content amidst the overwhelming volume of information available.
Kosmix
Series B in 2006
Kosmix is a web navigation platform that allows users to explore the Internet by topic, presenting an organized dashboard of relevant videos, photos, news, commentary, and links. Founded in 2005 by Venky Harinarayan and Anand Rajaraman in Mountain View, California, Kosmix employs a content categorization engine to filter and organize information, helping users navigate the web effectively even when they are unsure of their specific interests. The company's initial foray into vertical search was marked by the launch of RightHealth.com, which has since become a leading health site. In 2008, Kosmix expanded its focus to provide a broader range of topic-based exploration. The company has received funding from notable investors, including Accel Partners, Lightspeed Venture Partners, and Bezos Expeditions, and aims to streamline the way users discover and interact with online content amidst the overwhelming volume of information available.
Kosmix
Series A in 2005
Kosmix is a web navigation platform that allows users to explore the Internet by topic, presenting an organized dashboard of relevant videos, photos, news, commentary, and links. Founded in 2005 by Venky Harinarayan and Anand Rajaraman in Mountain View, California, Kosmix employs a content categorization engine to filter and organize information, helping users navigate the web effectively even when they are unsure of their specific interests. The company's initial foray into vertical search was marked by the launch of RightHealth.com, which has since become a leading health site. In 2008, Kosmix expanded its focus to provide a broader range of topic-based exploration. The company has received funding from notable investors, including Accel Partners, Lightspeed Venture Partners, and Bezos Expeditions, and aims to streamline the way users discover and interact with online content amidst the overwhelming volume of information available.
Vasca
Venture Round in 2000
Vasca is a medical device company that provides technologies to improve body access for therapeutic interventions in the United States and European Union. The company develops, manufactures, and markets LifeSite, a subcutaneous device that combines a valve with cannulas, which are used for the treatment of chronic renal failure. Vasca was founded in 1996 and is based in Tewksbury, Massachusetts, United States.
Firstsource Solutions
Venture Round in 2000
Firstsource Solutions Limited is a business process management company headquartered in Mumbai, India, specializing in customized outsourced services across the customer lifecycle. Founded in 2001, it operates globally with a strong presence in the United States, the United Kingdom, and the Philippines. The company provides a wide range of services, including customer acquisition, account servicing, collections, payroll, and tax management. It also offers specialized solutions in healthcare, such as revenue cycle management and telehealth support, along with contact center and back-office processing services. Firstsource serves various sectors, including banking and financial services, healthcare, telecommunications, media, insurance, and utilities, with a significant portion of its revenue generated from the banking sector. The company was formerly known as ICICI Onesource Limited and rebranded to Firstsource Solutions Limited in 2006.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.